This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
TEVA-GABAPENTIN
TEVA CANADA LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TEVA-GABAPENTIN in Canada?
Yes. TEVA-GABAPENTIN 300MG has an active shortage reported to Health Canada (last updated June 4, 2026).
Why is TEVA-GABAPENTIN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TEVA-GABAPENTIN be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02244514
Strength
300MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
GABAPENTIN
Tier
Unrated
Last Updated
2026-06-16
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
TEVA-GABAPENTIN has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646